Antiretroviral Pharmacology Training in Resource Poor Countries

资源匮乏国家的抗逆转录病毒药理学培训

基本信息

  • 批准号:
    8049690
  • 负责人:
  • 金额:
    $ 30.01万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-04-08 至 2014-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This is a revised AITRP proposal for a postgraduate training initiative with an emphasis on HIV/AIDS clinical pharmacology between the University at Buffalo (UB) and the University of Zimbabwe (UZ). The program faculty at both institutions are experienced investigators that will contribute mentored training to UZ students who, in turn, will contribute clinical pharmacology expertise to multidisciplinary teams to achieve the HIV/AIDS research goals for Zimbabwe. The program is designed for AITRP trainees to benefit from mentored interactions with faculty and health professionals with established clinical/translational and laboratory research environments. The AITRP infrastructure has been broadened to include formalized collaboration with NIAID-funded international, multidisciplinary research networks in Zimbabwe, coordinated through the UZ Clinical Trials Site, as well as other US-supported and Zimbabwe-based research programs. This approach will provide opportunities for AITRP trainees to develop their research career during the AITRP and then continue in a collaborative, mentored environment after the training period. This revised application includes a focused didactic curriculum for postgraduate trainees and an integrated research project experience that includes on-site training at UB and UZ. The AITRP will focus on a group of highly trained individuals who will then pursue their research programs within the multidisciplinary environment that is present at UZ with continued mentoring and career development. Strong institutional support for the proposed AITRP is evident through participation of faculty and administrative leaders at UZ in recognition of the need to support the development of future researchers to address the HIV/AIDS epidemic in Zimbabwe. PUBLIC HEALTH RELEVANCE: As the HIV/AIDS epidemic has continued to impact on developing countries, the need for training in HIV/AIDS clinical Pharmacology has also expanded in scope. Our AITRP meets these needs by providing a mechanism for multi-disciplinary training to conduct HIV/AIDS treatment research and achieve the goals that Zimbabwe has established for optimizing antiretroviral therapy and expanding its pool of clinician scientists.
描述(由申请人提供):这是一个修订后的AITRP建议的研究生培训计划,重点是在布法罗大学(UB)和津巴布韦大学(UZ)之间的艾滋病毒/艾滋病临床药理学。这两个机构的计划教师都是经验丰富的研究人员,他们将为UZ学生提供指导培训,反过来,他们将为多学科团队提供临床药理学专业知识,以实现津巴布韦的艾滋病毒/艾滋病研究目标。该计划是专为AITRP学员受益于导师与教师和卫生专业人员与建立临床/翻译和实验室研究环境的互动。AITRP的基础设施已经扩大到包括与NIAID资助的国际合作,津巴布韦的多学科研究网络,通过UZ临床试验网站以及其他美国支持和津巴布韦的研究计划进行协调。这种方法将为AITRP学员提供机会,在AITRP期间发展他们的研究生涯,然后在培训期结束后继续在协作,指导的环境中。这个修订后的应用程序包括研究生学员的重点教学课程和综合研究项目的经验,包括在UB和UZ的现场培训。AITRP将专注于一群训练有素的个人,他们将在UZ的多学科环境中继续进行他们的研究计划,并继续进行指导和职业发展。对拟议的AITRP的强有力的机构支持是显而易见的,通过在UZ的教师和行政领导人的参与,认识到需要支持未来的研究人员的发展,以解决艾滋病毒/艾滋病在津巴布韦的流行。公共卫生关系:由于艾滋病毒/艾滋病的流行继续影响发展中国家,对艾滋病毒/艾滋病临床药理学培训的需求范围也扩大了。我们的AITRP通过提供多学科培训机制来满足这些需求,以进行艾滋病毒/艾滋病治疗研究,并实现津巴布韦为优化抗逆转录病毒疗法和扩大临床科学家人才库而制定的目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gene D. Morse其他文献

Clinical Pharmacokinetics of Non-Nucleoside Reverse Transcriptase Inhibitors
  • DOI:
    10.2165/00003088-200140120-00002
  • 发表时间:
    2001-01-01
  • 期刊:
  • 影响因子:
    4.000
  • 作者:
    Patrick F. Smith;Robert DiCenzo;Gene D. Morse
  • 通讯作者:
    Gene D. Morse
Compendial testing of antiretroviral drug reference standards for metrologic traceability: Bictegravir and cabotegravir
  • DOI:
    10.1007/s00769-025-01634-0
  • 发表时间:
    2025-04-07
  • 期刊:
  • 影响因子:
    1.000
  • 作者:
    Troy D. Wood;Richard W. Browne;Erin R. Tiede;Connor E. Gould;Diala Ghazal;Robin DiFrancesco;Gene D. Morse
  • 通讯作者:
    Gene D. Morse
Medical and Pharmacy Students’ Awareness, Knowledge, and Attitudes Toward Injectable HIV Pre-Exposure Prophylaxis (PrEP)
  • DOI:
    10.1007/s10900-025-01479-1
  • 发表时间:
    2025-05-21
  • 期刊:
  • 影响因子:
    2.200
  • 作者:
    Jacob Bleasdale;Amy Hequembourg;Gene D. Morse;Sarahmona M. Przybyla
  • 通讯作者:
    Sarahmona M. Przybyla
Mycobacterium Tuberculosis and Interactions with the Host Immune System: Opportunities for Nanoparticle Based Immunotherapeutics and Vaccines
  • DOI:
    10.1007/s11095-018-2528-9
  • 发表时间:
    2018-11-08
  • 期刊:
  • 影响因子:
    4.300
  • 作者:
    Raymonde B. Bekale;Su-Mari Du Plessis;Nai-Jen Hsu;Jyoti R. Sharma;Samantha L. Sampson;Muazzam Jacobs;Mervin Meyer;Gene D. Morse;Admire Dube
  • 通讯作者:
    Admire Dube
Tenofovir-associated kidney disease in Africans: a systematic review
  • DOI:
    10.1186/s12981-019-0227-1
  • 发表时间:
    2019-06-06
  • 期刊:
  • 影响因子:
    2.500
  • 作者:
    Takudzwa J. Mtisi;Chiratidzo E. Ndhlovu;Chiedza C. Maponga;Gene D. Morse
  • 通讯作者:
    Gene D. Morse

Gene D. Morse的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gene D. Morse', 18)}}的其他基金

HIV Research Training Program
艾滋病毒研究培训计划
  • 批准号:
    9889198
  • 财政年份:
    2016
  • 资助金额:
    $ 30.01万
  • 项目类别:
CLINICAL PHARMACOLOGY QUALITY ASSURANCE AND QUALITY CONTROL
临床药理学质量保证和质量控制
  • 批准号:
    8089738
  • 财政年份:
    2010
  • 资助金额:
    $ 30.01万
  • 项目类别:
Antiretroviral Pharmacology Training in Resource Poor Countries
资源匮乏国家的抗逆转录病毒药理学培训
  • 批准号:
    7680562
  • 财政年份:
    2009
  • 资助金额:
    $ 30.01万
  • 项目类别:
Antiretroviral Pharmacology Training in Resource Poor Countries
资源匮乏国家的抗逆转录病毒药理学培训
  • 批准号:
    7918885
  • 财政年份:
    2009
  • 资助金额:
    $ 30.01万
  • 项目类别:
Antiretroviral Pharmacology Training in Resource Poor Countries
资源匮乏国家的抗逆转录病毒药理学培训
  • 批准号:
    7908275
  • 财政年份:
    2009
  • 资助金额:
    $ 30.01万
  • 项目类别:
Antiretroviral Pharmacology Training in Resource Poor Countries
资源匮乏国家的抗逆转录病毒药理学培训
  • 批准号:
    8248741
  • 财政年份:
    2009
  • 资助金额:
    $ 30.01万
  • 项目类别:
Antiretroviral Pharmacology Training in Resource Poor Countries
资源匮乏国家的抗逆转录病毒药理学培训
  • 批准号:
    8458097
  • 财政年份:
    2009
  • 资助金额:
    $ 30.01万
  • 项目类别:
CLINICAL PHARMACOLOGY QUALITY ASSURANCE AND QUALITY CONTROL
临床药理学质量保证和质量控制
  • 批准号:
    7891925
  • 财政年份:
    2008
  • 资助金额:
    $ 30.01万
  • 项目类别:
AMPRENAVIR AND EFAVIRENZ PHARMACOKINETICS BEFORE AND AFTER THE ADDITION OF
安普那韦和依非韦伦添加前后的药代动力学
  • 批准号:
    7355259
  • 财政年份:
    2006
  • 资助金额:
    $ 30.01万
  • 项目类别:
TDM & Drug Interactions in HIVinfected Substance Abusers
时分复用
  • 批准号:
    6759387
  • 财政年份:
    2003
  • 资助金额:
    $ 30.01万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 30.01万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.01万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 30.01万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.01万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 30.01万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.01万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 30.01万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 30.01万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 30.01万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.01万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了